Evidence map›Paper›PMID 37064228›Full record

ArticleFrontiers in bioengineering and biotechnology2023

Isolation and screening of a chitin deacetylase producing

Yingying Zhang, Xi Luo, Longfei Yin, Fengwei Yin, Weilong Zheng, Yongqian Fu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Characterization of extracellular chitin deacetylase fromCurrent research in microbial sciences · 2025
    Article
  4. Review
  5. Review
  6. A new strain ofFrontiers in microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yingying ZhangTaizhou Key Laboratory of Biomass Functional Materials Development and Application, Taizhou University, Taizhou, Zhejiang, China.
Xi LuoTaizhou Key Laboratory of Biomass Functional Materials Development and Application, Taizhou University, Taizhou, Zhejiang, China.
Longfei YinTaizhou Key Laboratory of Biomass Functional Materials Development and Application, Taizhou University, Taizhou, Zhejiang, China.
Fengwei YinTaizhou Key Laboratory of Biomass Functional Materials Development and Application, Taizhou University, Taizhou, Zhejiang, China.
Weilong ZhengTaizhou Key Laboratory of Biomass Functional Materials Development and Application, Taizhou University, Taizhou, Zhejiang, China.
Yongqian FuTaizhou Key Laboratory of Biomass Functional Materials Development and Application, Taizhou University, Taizhou, Zhejiang, China.
Taizhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chitosan is a biopolymer material extracted from marine biomass waste such as shrimp and crab shells, which has good biocompatibility and degradability with great potential for application in the field of wastewater treatment and soil remediation. The higher the degree of deacetylation (DD), the better the adsorption performance of chitosan. Chitin deacetylase (CDA) can specifically catalyze the deacetylate of chitin in a green reaction that is environmentally friendly. However, the scarcity of high yielding chitin deacetylase strains has been regarded as the technical bottleneck of chitosan green production. Here, we screened a natural chitin degrading bacterium from coastal mud and identified it as

Indexed as

Bacillus cereuschitin deacetylasechitosandegree of deacetylationgreen preparation

Identifiers

PMID37064228
PMCPMC10098122
OpenAlexW4361274702

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.